Cargando…
Obstructive sleep apnea therapy for cardiovascular risk reduction—Time for a rethink?
Obstructive sleep apnea (OSA) is a highly prevalent and underdiagnosed medical condition, which is associated with various cardiovascular and metabolic diseases. The current mainstay of therapy is continuous positive airway pressure (CPAP); however, CPAP is known to be poorly accepted and tolerated...
Autores principales: | Dissanayake, Hasthi U., Colpani, Juliana T., Sutherland, Kate, Loke, Weiqiang, Mohammadieh, Anna, Ou, Yi‐Hui, de Chazal, Philip, Cistulli, Peter A., Lee, Chi‐Hang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715402/ https://www.ncbi.nlm.nih.gov/pubmed/34791676 http://dx.doi.org/10.1002/clc.23747 |
Ejemplares similares
-
Does obstructive sleep apnoea modulate cardiac autonomic function in paroxysmal atrial fibrillation?
por: Mohammadieh, Anna Mary, et al.
Publicado: (2022) -
Comparative associations of oximetry patterns in Obstructive Sleep Apnea with incident cardiovascular disease
por: Sutherland, Kate, et al.
Publicado: (2022) -
The effect of obstructive sleep apnea therapy on cardiovascular autonomic function: a systematic review and meta-analysis
por: Dissanayake, Hasthi U, et al.
Publicado: (2022) -
P095 Heart Rate Variability during Sleep in Paroxysmal Atrial Fibrillation patients with and without Obstructive Sleep Apnoea
por: Mohammadieh, A, et al.
Publicado: (2021) -
P151 Short-term mandibular advancement splint therapy for Obstructive Sleep Apnoea improves parasympathetic modulation
por: Ucak, S, et al.
Publicado: (2021)